phenobarbital has been researched along with Neurocysticercosis in 3 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
Neurocysticercosis: Infection of the brain, spinal cord, or perimeningeal structures with the larval forms of the genus TAENIA (primarily T. solium in humans). Lesions formed by the organism are referred to as cysticerci. The infection may be subacute or chronic, and the severity of symptoms depends on the severity of the host immune response and the location and number of lesions. SEIZURES represent the most common clinical manifestation although focal neurologic deficits may occur. (From Joynt, Clinical Neurology, 1998, Ch27, pp46-50)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The pharmacokinetic parameters were analyzed by analysis of variance followed by the Tukey-Kramer test." | 6.70 | Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. ( Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM, 2002) |
| "Cysticercosis is a neglected tropical disease set as health priority by WHO." | 5.56 | [Disseminated cysticercosis affecting the brain, the eye and the skin on a Senegalese patient]. ( Diallo, K; Diallo, M; Dione, MAD; Diop, A; Manga, NM; Wembulua, BS, 2020) |
| " The pharmacokinetic parameters were analyzed by analysis of variance followed by the Tukey-Kramer test." | 2.70 | Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis. ( Dreossi, SA; Garcia, FS; Lanchote, VL; Takayanagui, OM, 2002) |
| "Cysticercosis is a neglected tropical disease set as health priority by WHO." | 1.56 | [Disseminated cysticercosis affecting the brain, the eye and the skin on a Senegalese patient]. ( Diallo, K; Diallo, M; Dione, MAD; Diop, A; Manga, NM; Wembulua, BS, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Wembulua, BS | 1 |
| Diallo, K | 1 |
| Diallo, M | 1 |
| Dione, MAD | 1 |
| Diop, A | 1 |
| Manga, NM | 1 |
| Okome-Nkoumou, MM | 1 |
| Ondounda, M | 1 |
| Dzeing-Ella, A | 1 |
| Mounguengui, D | 1 |
| Madjinou, MI | 1 |
| Clevenbergh, P | 1 |
| Magne, C | 1 |
| Nzenze, JR | 1 |
| Lanchote, VL | 1 |
| Garcia, FS | 1 |
| Dreossi, SA | 1 |
| Takayanagui, OM | 1 |
1 trial available for phenobarbital and Neurocysticercosis
| Article | Year |
|---|---|
Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
Topics: Adult; Albendazole; Anthelmintics; Anticonvulsants; Area Under Curve; Carbamazepine; Chromatography, | 2002 |
2 other studies available for phenobarbital and Neurocysticercosis
| Article | Year |
|---|---|
[Disseminated cysticercosis affecting the brain, the eye and the skin on a Senegalese patient].
Topics: Aged; Albendazole; Brain; Cysticercosis; Diagnosis, Differential; Eye; Eye Infections, Parasitic; Fe | 2020 |
Epileptiform seizures revealing neurocysticercosis: report of two clinical cases in Libreville, Gabon.
Topics: Adrenal Cortex Hormones; Adult; Albendazole; Animals; Antibodies, Helminth; Anticestodal Agents; Fem | 2010 |